Quick Answer
Odyssey Health, Inc. reported Total Revenue of $0.00 for fiscal year 2020.
Odyssey Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | $0.00 |
| Net Income | -$1.74M -106.9% |
-$842.3K +85.8% |
-$5.92M +29.9% |
-$8.44M +50.0% |
-$16.88M -288.2% |
-$4.35M +81.4% |
| Diluted EPS | -$0.02 -100.0% |
-$0.01 +85.7% |
-$0.07 +22.2% |
-$0.09 +50.0% |
-$0.18 | — |
| Total Assets | $49.7K -91.5% |
$586.1K +28.6% |
$455.8K -20.0% |
$569.7K -6.7% |
$610.5K +478.2% |
$105.6K -80.3% |
| Cash and Equivalents | — | — | — | — | $556.6K +784.1% |
$63.0K -62.3% |
| Long-Term Debt | — | — | — | — | $0.00 -100.0% |
$50.0K |
| Stockholders Equity | -$6.95M -30.4% |
-$5.33M +13.4% |
-$6.16M -32.6% |
-$4.64M -67.8% |
-$2.77M -324.8% |
-$651.5K -9.7% |
| R&D Expense | $0.00 -100.0% |
$55.2K | — | — | — | — |
| Operating Income | -$1.02M +52.3% |
-$2.14M +59.7% |
-$5.31M +34.4% |
-$8.11M +48.9% |
-$15.86M -312.3% |
-$3.85M +83.7% |
| Gross Profit | — | — | — | — | — | $0.00 |
| Shares Outstanding | 96.71M +0.0% |
96.71M +22.3% |
79.07M +1.6% |
77.86M -10.7% |
87.19M -1.5% |
88.56M +1.8% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | April 30, 2020 | $0.00 | — | — |
| Net Income | January 31, 2026 | -$3.60M | -1536.2% | -645.0% |
| Diluted EPS | January 31, 2026 | -$0.03 | — | — |
| Total Assets | January 31, 2026 | $721.3K | +170.3% | +402.2% |
| Cash and Equivalents | October 31, 2021 | $471.1K | +60.9% | -15.4% |
| Long-Term Debt | April 30, 2021 | $0.00 | — | -100.0% |
| Stockholders Equity | January 31, 2026 | -$10.60M | -64.0% | -48.1% |
| R&D Expense | April 30, 2025 | $0.00 | — | — |
| Operating Income | January 31, 2026 | -$181.9K | -16.2% | +40.0% |
| Gross Profit | April 30, 2020 | $0.00 | — | — |
| Shares Outstanding | January 31, 2026 | 99.85M | +3.3% | +0.0% |
- Odyssey Health, Inc. reported Total Revenue of $0.00 for fiscal year 2020.
- Odyssey Health, Inc. reported Net Income of -$1.74 million for fiscal year 2025.
- Odyssey Health, Inc. showed a decrease of -106.9% in Net Income compared to the prior fiscal year.
- Odyssey Health, Inc. reported Diluted EPS of $0.02 per share (loss) for fiscal year 2025.
- Odyssey Health, Inc. showed a decrease of -100.0% in Diluted EPS compared to the prior fiscal year.
- Odyssey Health, Inc. reported Total Assets of $49.7 thousand for fiscal year 2025.
- Odyssey Health, Inc. showed a decrease of -91.5% in Total Assets compared to the prior fiscal year.
- Odyssey Health, Inc. reported Cash and Equivalents of $556.6 thousand for fiscal year 2021.
- Odyssey Health, Inc. showed an increase of +784.1% in Cash and Equivalents compared to the prior fiscal year.
- Odyssey Health, Inc. reported Long-Term Debt of $0.00 for fiscal year 2021.
- Odyssey Health, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Odyssey Health, Inc. reported Stockholders Equity of -$6.95 million for fiscal year 2025.
- Odyssey Health, Inc. showed a decrease of -30.4% in Stockholders Equity compared to the prior fiscal year.
- Odyssey Health, Inc. reported R&D Expense of $0.00 for fiscal year 2025.
- Odyssey Health, Inc. showed a decrease of -100.0% in R&D Expense compared to the prior fiscal year.
- Odyssey Health, Inc. reported Operating Income of -$1.02 million for fiscal year 2025.
- Odyssey Health, Inc. showed an increase of +52.3% in Operating Income compared to the prior fiscal year.
- Odyssey Health, Inc. reported Gross Profit of $0.00 for fiscal year 2020.
- Odyssey Health, Inc. reported Shares Outstanding of 96.71 million shares for fiscal year 2025.
- Odyssey Health, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: